Intelligence Platform
Patents
Browse 206 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6864103
Phthalamide-lanthanide complexes for use as luminescent markers
expired patentUS 6794150
Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
expired patentUS 6756210
Linoleic acid diol and glucuronide conjugate levels as diagnostic markers of disorders of
expired patentUS 6680172
Treatments and markers for cancers of the central nervous system
expired patentUS 6656917
Compositions and methods for targeted enzymatic release of cell regulatory compounds
expired patentUS 6653100
hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and
expired patentUS 6645465
Annexin proteins and autoantibodies as serum markers for cancer
expired patentUS 6579684
Assay of YKL-40 as a marker for cancer
expired patentUS 6515113
Phthalamide lanthanide complexes for use as luminescent markers
expired patentUS 6512091
Genetic Markers for breast, ovarian, and prostatic cancer
expired patentUS 6506374
Hair coloring composition and method
expired patentUS 6309634
Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)
expired patentUS 6165719
hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and
expired patentUS 6136532
Methods for treating bipolar mood disorder associated with markers on chromosome 18q
expired